Lista de obras - Pedro P López-Casas - Dominio Público Uruguay

A Tricin Derivative from Deschampsia antarctica Desv. Inhibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response.

artículo científico publicado en 2018

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

artículo científico publicado en 2015

A multifunctional drug nanocarrier for efficient anticancer therapy

scientific article published on 08 December 2018

Afatinib restrains K-RAS–driven lung tumorigenesis

artículo científico publicado en 2018

An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity

artículo científico publicado en 2012

Changes in vinexin expression patterns in the mouse testis induced by developmental exposure to 17beta-estradiol.

artículo científico publicado en 2007

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

artículo científico publicado en 2016

Colorectal cancer classification based on gene expression is not associated with FOLFIRI response

Developmental regulation of expression of Ran/M1 and Ran/M2 isoforms of Ran-GTPase in mouse testis.

artículo científico publicado en 2003

Discovery of new targets to control metastasis in pancreatic cancer by single cell transcriptomics analysis of circulating tumor cells

scientific article published on 04 June 2020

Expression of stress inducible protein 1 (Stip1) in the mouse testis

artículo científico publicado en 2006

Gene silencing by RNAi in mouse Sertoli cells

artículo científico publicado en 2008

Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

artículo científico publicado en 2020

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-Mediated Resistance to Type I MET Inhibitors in Nonclinical Models.

artículo científico publicado en 2017

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

artículo científico publicado en 2019

Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment

artículo científico publicado en 2014

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

artículo científico publicado en 2020

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models.

artículo científico publicado en 2016

MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

artículo científico publicado en 2018

Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer.

artículo científico publicado en 2014

Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.

artículo científico publicado en 2015

New scaffolds for the design of selective estrogen receptor modulators

artículo científico publicado en 2008

OMTX705, a Novel FAP-Targeting ADC demonstrates Activity in Chemotherapy and PD1-Resistant Solid Tumors Models

artículo científico publicado en 2020

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.

artículo científico publicado en 2018

Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective

artículo científico publicado en 2017

Personalized RNA-medicine for pancreatic cancer

artículo científico publicado en 2018

Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors

artículo científico publicado en 2015

Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

artículo científico publicado en 2018

Phosphoprotein enriched in astrocytes-15 is expressed in mouse testis and protects spermatocytes from apoptosis.

artículo científico publicado en 2007

Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft ⬇️

artículo científico publicado el 19 de diciembre de 2011

Ran GTPase expression during early development of the mouse embryo.

artículo científico publicado en 2002

Regulation of flotillin-1 in the establishment of NIH-3T3 cell-cell interactions.

artículo científico publicado en 2003

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.

artículo científico publicado en 2014

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

artículo científico

SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts

artículo científico publicado en 2016

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

artículo científico publicado en 2013

The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis.

artículo científico publicado en 2012

The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis.

artículo científico publicado en 2008

Transcriptional dissection of pancreatic tumors engrafted in mice.

artículo científico publicado en 2014

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

artículo científico publicado en 2020

Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression

artículo científico publicado en 2015

c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.

artículo científico publicado en 2018

Lista de obras de Pedro P López-Casas

A Tricin Derivative from Deschampsia antarctica Desv. Inhibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response.

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

A multifunctional drug nanocarrier for efficient anticancer therapy

Afatinib restrains K-RAS–driven lung tumorigenesis

An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity

Changes in vinexin expression patterns in the mouse testis induced by developmental exposure to 17beta-estradiol.

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

Colorectal cancer classification based on gene expression is not associated with FOLFIRI response

Developmental regulation of expression of Ran/M1 and Ran/M2 isoforms of Ran-GTPase in mouse testis.

Discovery of new targets to control metastasis in pancreatic cancer by single cell transcriptomics analysis of circulating tumor cells

Expression of stress inducible protein 1 (Stip1) in the mouse testis

Gene silencing by RNAi in mouse Sertoli cells

Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-Mediated Resistance to Type I MET Inhibitors in Nonclinical Models.

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models.

MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer.

Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.

New scaffolds for the design of selective estrogen receptor modulators

OMTX705, a Novel FAP-Targeting ADC demonstrates Activity in Chemotherapy and PD1-Resistant Solid Tumors Models

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.

Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective

Personalized RNA-medicine for pancreatic cancer

Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors

Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

Phosphoprotein enriched in astrocytes-15 is expressed in mouse testis and protects spermatocytes from apoptosis.

Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft ⬇️

Ran GTPase expression during early development of the mouse embryo.

Regulation of flotillin-1 in the establishment of NIH-3T3 cell-cell interactions.

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

The effects of different endocrine disruptors defining compound-specific alterations of gene expression profiles in the developing testis.

The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis.

Transcriptional dissection of pancreatic tumors engrafted in mice.

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression

c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.